Lupin Launches Topiramate Extended-Release Capsules in US Following FDA Approval
Lupin rolls out FDA-approved generic topiramate extended-release capsules in the US for epilepsy and migraine treatment.
IQVIA MAT | 05/02/2026 | By News Bureau | 210
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy